Literature DB >> 23538192

Mapping EQ-5D utility scores from the Incontinence Quality of Life Questionnaire among patients with neurogenic and idiopathic overactive bladder.

Stephen Kay1, Keith Tolley, Danielle Colayco, Kristin Khalaf, Peter Anderson, Denise Globe.   

Abstract

OBJECTIVES: To provide a mapping algorithm for estimating EuroQol five-dimensional (EQ-5D) questionnaire index scores from the Incontinence-specific Quality of Life questionnaire (I-QOL) based on nationally representative samples of patients with idiopathic or neurogenic overactive bladder (OAB) using EQ-5D questionnaire preference valuations based on both the UK and US general populations.
METHODS: Analyses were conducted for 2505 patients from the Adelphi Overactive Bladder Disease Specific Programme, a cross-sectional study of patients with idiopathic or neurogenic OAB, undertaken in the United States and Europe in 2010. A range of statistical modeling techniques was used. Tenfold cross-validation techniques were used to calculate mean absolute error (MAE) and root mean squared error (RMSE) goodness-of-fit statistics. Various predictor lists, together with a method combining stepwise selection with multivariable fractional polynomial techniques to allow nonlinear relationships to feature, were pursued.
RESULTS: Choice of predictors was consistent for both the UK and US EQ-5D questionnaire tariffs. For idiopathic, the best model included the I-QOL total score and age (both modeled nonlinearly.) For neurogenic, the best model was the I-QOL social embarrassment domain score modeled linearly only. Best-fit results were better in the idiopathic (n = 2351; MAE = 0.10; RMSE = 0.14) than in the neurogenic sample (n = 254; MAE = 0.17; RMSE = 0.22).
CONCLUSIONS: This research provides algorithms for mapping EQ-5D questionnaire index scores from the I-QOL, allowing calculation of appropriate preference-based health-related quality-of-life scores for use in cost-effectiveness analyses when only I-QOL data are available. The strongest results were for idiopathic patients, but those for neurogenic are consistent with those of other published mapping studies.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23538192     DOI: 10.1016/j.jval.2012.12.005

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  8 in total

1.  OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales.

Authors:  Nick Freemantle; Kristin Khalaf; Clara Loveman; Sanja Stanisic; Dmitry Gultyaev; Johanna Lister; Marcus Drake
Journal:  Eur J Health Econ       Date:  2015-10-19

2.  Mapping of the OAB-SF Questionnaire onto EQ-5D in Spanish Patients with Overactive Bladder.

Authors:  Miguel A Ruiz; Laura L Gutiérrez; Manuel Monroy; Javier Rejas
Journal:  Clin Drug Investig       Date:  2016-04       Impact factor: 2.859

3.  Short-stretch inelastic compression bandage in knee swelling following total knee arthroplasty study (STICKS): study protocol for a randomised controlled feasibility study.

Authors:  Timothy M Brock; Andrew P Sprowson; Scott Muller; Mike R Reed
Journal:  Trials       Date:  2015-03-11       Impact factor: 2.279

4.  Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.

Authors:  Michela Meregaglia; Ludovica Borsoi; John Cairns; Rosanna Tarricone
Journal:  Eur J Health Econ       Date:  2017-09-25

5.  Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module.

Authors:  Jesús Cuervo; Nacho Castejón; Kristin M Khalaf; Catherine Waweru; Denise Globe; Donald L Patrick
Journal:  Health Qual Life Outcomes       Date:  2014-10-08       Impact factor: 3.186

6.  Mapping of incontinence quality of life (I-QOL) scores to assessment of quality of life 8D (AQoL-8D) utilities in patients with idiopathic overactive bladder.

Authors:  Gang Chen; Jonathan T Tan; Kwong Ng; Angelo Iezzi; Jeffrey Richardson
Journal:  Health Qual Life Outcomes       Date:  2014-08-30       Impact factor: 3.186

7.  Testing and Treating Women after Unsuccessful Conservative Treatments for Overactive Bladder or Mixed Urinary Incontinence: A Model-Based Economic Evaluation Based on the BUS Study.

Authors:  Ilias Goranitis; Pelham Barton; Lee J Middleton; Jonathan J Deeks; Jane P Daniels; Pallavi Latthe; Arri Coomarasamy; Suneetha Rachaneni; Shanteela McCooty; Tina S Verghese; Tracy E Roberts
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  Mapping the Edmonton Symptom Assessment System-Revised: Renal to the EQ-5D-5L in patients with chronic kidney disease.

Authors:  Jiabi Wen; Xuejing Jin; Fatima Al Sayah; Hilary Short; Arto Ohinmaa; Sara N Davison; Michael Walsh; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2021-07-19       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.